SG Americas Securities
ARCT icon

SG Americas Securities’s Arcturus Therapeutics ARCT Stock Holding History

SG Americas Securities’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,972
Closed -$162K – 3360
2026
Q1 		$162K Buy
+20,972
New +$153K ﹤0.01% 2740
2025
Q4 		– Sell
-7,954
Closed -$147K – 3591
2025
Q3 		$147K Buy
+7,954
New +$128K ﹤0.01% 2907
2025
Q1 		– Sell
-11,940
Closed -$203K – 3464
2024
Q4 		$203K Buy
11,940
+3,705
+45% +$69.7K ﹤0.01% 2141
2024
Q3 		$191K Buy
+8,235
New +$176K ﹤0.01% 2538
2024
Q2 		– Sell
-8,758
Closed -$296K – 2836
2024
Q1 		$296K Sell
8,758
-24,520
-74% -$869K ﹤0.01% 1698
2023
Q4 		$1.05M Sell
33,278
-42,567
-56% -$1.01M 0.01% 997
2023
Q3 		$1.94M Buy
+75,845
New +$2.34M 0.02% 755
2023
Q2 		– Sell
-10,086
Closed -$242K – 2278
2023
Q1 		$242K Buy
+10,086
New +$181K ﹤0.01% 2287
2022
Q3 		– Sell
-22,678
Closed -$357K – 3173
2022
Q2 		$357K Buy
+22,678
New +$445K ﹤0.01% 2248
2022
Q1 		– Sell
-5,965
Closed -$221K – 2945
2021
Q4 		$221K Sell
5,965
-8,802
-60% -$359K ﹤0.01% 2617
2021
Q3 		$706K Buy
+14,767
New +$662K ﹤0.01% 2214
2021
Q2 		– Sell
-7,355
Closed -$304K – 2844
2021
Q1 		$304K Buy
+7,355
New +$438K ﹤0.01% 2364
2020
Q4 		– Sell
-17,931
Closed -$769K – 3324
2020
Q3 		$769K Buy
17,931
+10,551
+143% +$524K ﹤0.01% 1350
2020
Q2 		$345K Buy
+7,380
New +$254K ﹤0.01% 2414

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SG Americas Securities's ARCT Position: Q2 2026 in Review

SG Americas Securities sold out of Arcturus Therapeutics (ARCT) in Q2 2026, closing a stake of 20,972 shares — an estimated $162K sold.

SG Americas Securities first reported a position in ARCT in Q2 2020 and held it in 14 quarters. The position peaked at $1.94M in Q3 2023. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • SG Americas Securities reported no remaining Arcturus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 20,972 Arcturus Therapeutics shares in Q2 2026, an estimated $162K.
  • SG Americas Securities first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 14 quarters.
  • SG Americas Securities's Arcturus Therapeutics position peaked at $1.94M in Q3 2023.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.